Jos Kosterink

Prof. Jos Kosterink is a Professor of Hospital and Clinical Pharmacy at the University of Groningen, affiliated with the Faculty of Science and Engineering and the Faculty of Medical Sciences. He leads the Department of PharmacoTherapy, Epidemiology and Economics at the Groningen Research Institute of Pharmacy. His research focuses on clinical pharmacology, pharmacokinetics, and therapeutic drug monitoring, particularly in areas like infectious diseases (e.g., tuberculosis), oncology drug development, and personalized medicine. He holds roles such as Director of GUIDE (Graduate School of Medical Sciences) and chairs multiple committees related to drug exploration and patient registries.

Key research interests include optimizing drug efficacy and safety through pharmacokinetic modeling, targeted drug delivery systems, and biomarker-driven therapies. He has contributed to studies on novel vaccines (e.g., Vvax001 for HPV-related cancers) and therapeutic strategies for multidrug-resistant tuberculosis using host-directed therapies like azithromycin.

Prof. Kosterink has authored over 200 publications, with recent work addressing clinical validation of self-sampling techniques for inflammatory bowel disease, biosimilar monoclonal antibodies in cancer treatment, and pharmacometabolomics applications. He has received awards including the NVZA Medication Safety Award and recognition for best English publication in pharmacy.

His professional activities span academic leadership, regulatory advisory roles (e.g., Central Committee for Human Subject Research), and collaborations with industry and hospitals to address drug shortages and pricing challenges. He actively engages in public discourse on pharmaceutical policy, emphasizing sustainable drug access and innovation.